If a defined proportion of grafts fail to survive, the revision session is included and agreed in writing before you travel, not discussed afterwards. This matters less here than it would for an irreversible procedure, and we say so: a hair transplant can be revised, which is exactly why the terms should be settled while you still have leverage.
The threshold and the revision session it triggers are set out in writing before you fly, not discussed for the first time after a disappointing result.
A hair transplant is revisable and rarely urgent. We say so plainly rather than borrowing the urgency of an irreversible operation, because that would be the wrong kind of pressure for what this actually is.
The terms are easiest to agree before payment, not after. That is the entire reason to fix them now rather than "if it comes up."
A revision session is a defined remedy in your agreement, not an insurance policy against every possible result. It covers a graft-count threshold not being met; it does not cover a hairline design you simply change your mind about later. See the hairline design page for why that decision is made carefully up front instead.
It also does not cover complications, which are a different category and mostly early: a 2026 complications review puts folliculitis at 12.1%, numbness at around 2% and infection below 1%, and those are clinical matters for the operating surgeon rather than triggers for a graft-count remedy. Shedding around the grafts in the first two to eight weeks is not graft failure either, however much it looks like it. See shock loss, and note that the review advises waiting about 12 months for maturation before judging a result at all. A threshold assessed at week six would be assessed on the wrong evidence.
While pricing six markets for the comparison pages, we read every published price page and tariff we could find and looked for what each one promised if grafts failed. The answer was the same everywhere: nothing. Not a hostile term, not a narrow term: no term. Turkey's clinics publish package inclusions down to the hotel and the airport transfer; none of them publishes what happens if the transplant does not take.
Two honest readings of that, and we owe you both. The generous one is that graft failure is uncommon enough and case-specific enough that no clinic wants to write a formula for it, which is defensible. The less generous one is that an unwritten remedy is negotiated after payment, when the person who needs it has already flown home. We are betting that writing it down is worth something to you, and being straight about it, that bet is also the reason we can charge more.
Published price pages and tariffs checked across six markets: Cosmedica, Smile Hair Clinic and Dr. Serkan Aygin (Istanbul); NHT Japan (Tokyo); Hairtran (Bangkok); HairMD India; Modaol (Seoul) non-covered fee schedule; and Yonghe Medical (HKEX 02279) FY2025 annual report. None stated any revision or graft-failure term (https://www.resmigazete.gov.tr/eskiler/2023/05/20230506-11.htm), measured 2026-07-28. The numeric threshold in our own agreement is still being set with an actuarial basis rather than picked, so no percentage appears on this page yet; the structure above is what is settled, and the figure follows it rather than the reverse.